Lexeo Therapeutics, Common Stock Price Prediction
| LXEO Stock | 3.07 0.10 3.37% |
Momentum 20
Sell Stretched
Oversold | Overbought |
EPS Estimate Current Year (2.77) | Wall Street Target Price 22.43 | EPS Estimate Current Quarter (0.73) |
Using Lexeo Therapeutics, hype-based prediction, you can estimate the value of Lexeo Therapeutics, Common from the perspective of Lexeo Therapeutics, response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Lexeo Therapeutics, using Lexeo Therapeutics,'s stock options and short interest. It helps to benchmark the overall future attitude of investors towards Lexeo using crowd psychology based on the activity and movement of Lexeo Therapeutics,'s stock price.
Lexeo Therapeutics, Implied Volatility | 5.12 |
Lexeo Therapeutics,'s implied volatility exposes the market's sentiment of Lexeo Therapeutics, Common stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Lexeo Therapeutics,'s implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Lexeo Therapeutics, stock will not fluctuate a lot when Lexeo Therapeutics,'s options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Lexeo Therapeutics, to buy its stock at a price that has no basis in reality. In that case, they are not buying Lexeo because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Lexeo Therapeutics, after-hype prediction price | USD 2.87 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Lexeo |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lexeo Therapeutics,'s price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lexeo Therapeutics, After-Hype Price Prediction Density Analysis
As far as predicting the price of Lexeo Therapeutics, at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Lexeo Therapeutics, or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Lexeo Therapeutics,, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Lexeo Therapeutics, Estimiated After-Hype Price Volatility
In the context of predicting Lexeo Therapeutics,'s stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Lexeo Therapeutics,'s historical news coverage. Lexeo Therapeutics,'s after-hype downside and upside margins for the prediction period are 0.14 and 8.75, respectively. We have considered Lexeo Therapeutics,'s daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Lexeo Therapeutics, is moderately volatile at this time. Analysis and calculation of next after-hype price of Lexeo Therapeutics, is based on 3 months time horizon.
Lexeo Therapeutics, Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Lexeo Therapeutics, is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Lexeo Therapeutics, backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Lexeo Therapeutics,, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.19 | 5.88 | 0.20 | 2.03 | 5 Events / Month | 4 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.07 | 2.87 | 6.51 |
|
Lexeo Therapeutics, Hype Timeline
Lexeo Therapeutics, is now traded for 3.07. The entity has historical hype elasticity of -0.2, and average elasticity to hype of competition of 2.03. Lexeo is forecasted to decline in value after the next headline, with the price expected to drop to 2.87. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -6.51%, whereas the daily expected return is now at -1.19%. The volatility of related hype on Lexeo Therapeutics, is about 344.2%, with the expected price after the next announcement by competition of 5.10. About 91.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.73. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Lexeo Therapeutics, recorded a loss per share of 12.53. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 5 days. Check out Lexeo Therapeutics, Basic Forecasting Models to cross-verify your projections.Lexeo Therapeutics, Related Hype Analysis
Having access to credible news sources related to Lexeo Therapeutics,'s direct competition is more important than ever and may enhance your ability to predict Lexeo Therapeutics,'s future price movements. Getting to know how Lexeo Therapeutics,'s peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Lexeo Therapeutics, may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TTC | Toro Co | 2.31 | 8 per month | 0.00 | (0.07) | 2.85 | (3.18) | 8.48 | |
| CHD | Church Dwight | (0.17) | 11 per month | 1.22 | 0.11 | 2.35 | (1.79) | 5.77 | |
| WETO | Webus International Limited | (0.50) | 4 per month | 0.00 | (0.01) | 4.44 | (10.00) | 10.00 | |
| COIN | Coinbase Global | 2.56 | 8 per month | 0.00 | (0.16) | 6.32 | (8.27) | 26.02 | |
| CDNS | Cadence Design Systems | 4.19 | 10 per month | 0.00 | (0.08) | 2.43 | (3.80) | 12.93 | |
| PG | Procter Gamble | 1.86 | 8 per month | 0.00 | 0.05 | 1.67 | (2.18) | 8.13 |
Lexeo Therapeutics, Additional Predictive Modules
Most predictive techniques to examine Lexeo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Lexeo using various technical indicators. When you analyze Lexeo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Lexeo Therapeutics, Predictive Indicators
The successful prediction of Lexeo Therapeutics, stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Lexeo Therapeutics, Common, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Lexeo Therapeutics, based on analysis of Lexeo Therapeutics, hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Lexeo Therapeutics,'s market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Lexeo Therapeutics,'s related companies. | 2022 | 2023 | 2024 | 2025 (projected) | Current Ratio | 5.58 | 7.21 | 8.29 | 7.88 | Net Debt To EBITDA | 1.1 | 1.65 | 1.89 | 3.08 |
Story Coverage note for Lexeo Therapeutics,
The number of cover stories for Lexeo Therapeutics, depends on current market conditions and Lexeo Therapeutics,'s risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Lexeo Therapeutics, is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Lexeo Therapeutics,'s long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Lexeo Therapeutics, Short Properties
Lexeo Therapeutics,'s future price predictability will typically decrease when Lexeo Therapeutics,'s long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Lexeo Therapeutics, Common often depends not only on the future outlook of the potential Lexeo Therapeutics,'s investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lexeo Therapeutics,'s indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 26.6 M | |
| Cash And Short Term Investments | 121.5 M |
Check out Lexeo Therapeutics, Basic Forecasting Models to cross-verify your projections. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lexeo Therapeutics,. If investors know Lexeo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lexeo Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Lexeo Therapeutics, is measured differently than its book value, which is the value of Lexeo that is recorded on the company's balance sheet. Investors also form their own opinion of Lexeo Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Lexeo Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lexeo Therapeutics,'s market value can be influenced by many factors that don't directly affect Lexeo Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lexeo Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Lexeo Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lexeo Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.